Skip to main content

Table 3 Multispecific CAR-T cell therapy in solid tumors

From: Tumor buster - where will the CAR-T cell therapy ‘missile’ go?

Condition

Targeting

domain

Reference

HCC

CD70/B7H3

[189, 414, 432,433,434]

 

GPC3/CD147

 
 

c-MET/PD-L1

 
 

GPC3/ASGR1

gp100/HER2

 

Glioma

CD70/B7H3

[189, 374,375,376, 435, 436]

 

HER2/IL13Rα2

 
 

EGFRvIII/IL13Rα2 OR EphA2; MOG/IL13Rα2 OR EphA2

 
 

EGFRvIII/IL13Rα2 OR CD133

 
 

HER2/IL13Rα2/EphA2

 
 

IL13Rα2/ EphA2

 

GC

Trop2/PD-L1

[277]

PC

MSLN/CEA

[437, 438]

 

MSLN/PSMA

 

EC

CD70/B7H3

[189]

CRC

CD30/CEA;

CD30/TAG70

[439]

BC

CD70/B7H3

[189, 414, 440,441,442]

 

Her2/IGF1R

 
 

MUC1/HER2

 
 

ROR1/B7H3

gp100/HER2

 

PCa

MSLN/PSMA

[437]

LCa

CD70/B7H3

[189, 204, 442]

 

ROR1/B7H3

PSCA/MUC1

 

OC

FLOR1/MSLN

[330, 333, 334]

 

ALPPL2/MCAM

ALPPL2/MSLN

ALPPL2/HER2

PD-L1/MUC16

 

MEL

CD70/B7H3

gp100/CSPG4

gp100/VEGFR-2

[189, 314, 443]